- Report
- January 2020
- 40 Pages
India
From €2494EUR$2,595USD£2,139GBP
- Report
- January 2020
- 40 Pages
France
From €2494EUR$2,595USD£2,139GBP
- Report
- September 2023
- 89 Pages
From €2835EUR$2,950USD£2,431GBP
- Report
- February 2024
- 105 Pages
Global
From €3500EUR$3,901USD£3,106GBP
- Report
- January 2024
- 78 Pages
Global
From €3500EUR$3,901USD£3,106GBP
- Report
- January 2020
- 40 Pages
United States
From €2494EUR$2,595USD£2,139GBP
- Report
- January 2020
- 40 Pages
Russia
From €2494EUR$2,595USD£2,139GBP
- Report
- January 2020
- 40 Pages
Ireland
From €2494EUR$2,595USD£2,139GBP
- Report
- January 2020
- 40 Pages
Germany
From €2494EUR$2,595USD£2,139GBP
- Report
- January 2020
- 40 Pages
China
From €2494EUR$2,595USD£2,139GBP
- Report
- January 2020
- 40 Pages
Brazil
From €2494EUR$2,595USD£2,139GBP
- Report
- January 2020
- 80 Pages
Africa
From €3648EUR$3,795USD£3,128GBP
- Report
- May 2023
- 140 Pages
Global
From €5766EUR$5,999USD£4,945GBP
The Travel Vaccine market is a subset of the Vaccine market, focusing on vaccines that are recommended for travelers. These vaccines are typically recommended for those who are traveling to areas with a higher risk of certain diseases, such as yellow fever, typhoid, and hepatitis A and B. Travel vaccines are typically administered by a healthcare provider, and may require multiple doses over a period of time.
The Travel Vaccine market is a growing sector, with an increasing number of travelers seeking protection from diseases that may be present in their destination countries. Vaccines are also becoming more widely available, with many countries now offering travel vaccines as part of their public health programs.
Some companies in the Travel Vaccine market include Sanofi Pasteur, GlaxoSmithKline, Merck, Pfizer, and Novartis. Show Less Read more
